Results on efficacy of the first of the SARS-CoV-2 candidate vaccines has been announced by Pfizer this week. The company states that the viral spike-encoding mRNA vaccine candidate was found to be more than 90% effective in preventing COVID-19. This announcement is good news, but in itself does not signal ...

Mady Hornig, Fiona Lowenstein, and David Tuller join TWiV to discuss patients with long-term COVID and similarities and differences with ME/CFS. Click arrow to playDownload TWiV 680 (67 MB .mp3, 112 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv

Daniel Griffin provides a clinical report on COVID-19, Slovlakia's plan to test all adults for SARS-CoV-2 infection, viral variants arising in Danish mink and their potential threat to humans, why it is unethical to carry out challenge trials, Nipah virus dynamics in bats and spillovers into humans, and direct cardiac ...

by Gertrud U. Rey Throughout the current pandemic, there has been a lot of talk about T cells and their role in protecting against SARS-CoV-2 infection and disease. Some data suggest that 20-50% of people with no prior exposure to SARS-CoV-2 have T cells that recognize SARS-CoV-2 peptides, and that ...

In this short video, I take you through some of the science books on my bookshelf, next to the desk where lately I have been spending a lot of time on Zoom. Not surprisingly, most of the books are about viruses.